Medicinal Products

Dáil Éireann Debate, Thursday - 11 July 2024

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Thursday, 11 July 2024

Questions (418)

Róisín Shortall

Question:

418. Deputy Róisín Shortall asked the Minister for Health the status of the application for reimbursement of the drugs Ibrutinib and venetoclax, used for the treatment of patients with previously untreated chronic lymphocytic leukaemia; and if he will make a statement on the matter. [30810/24]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer